Cell therapy

Cell therapy is the introduction of selected, and sometimes engineered, cells into a patient, harnessing the power of a patient’s immune system to combat their disease. The therapy may have wide applications as a cancer treatment, with the potential for cure in some patients.

Syncona has a world-leading cell therapy franchise developing products with the potential to treat patients across a range of diseases.

The Syncona team has established and built fully integrated companies with best-in-class manufacturing capabilities and world-leading management teams across innovative areas of cell therapy including: CAR-T, Tumour Infiltrating Lymphocytes, TCRs, T-Regulatory cells, iPSCs and macrophages.

Key facts

Unless stated all financials at 31 March 2023


Value of cell therapy portfolio


Number of clinical trials


Portfolio company Board seats

Our cell therapy portfolio companies

Our domain areas

Syncona has deep domain expertise across four key therapeutic areas.